| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal BSE Healthcare ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.18 |
| Equity |
99.82 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
39.74% |
| Top 10 Holdings |
56.86% |
| Top 25 Holdings |
77.76% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
75.21 |
| Healthcare |
24.61 |
| Cash |
0.18 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.39 |
| PE Ratio |
33.14 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
14.18 |
| DIVI LABORATORIES LTD |
6.60 |
| Max Healthcare Institute Limited |
6.51 |
| Cipla Limited |
6.48 |
| Dr Reddys Laboratories Limited |
5.97 |
| Apollo Hospitals Enterprise Limited |
5.42 |
| Lupin Limited |
3.71 |
| Fortis Health Care Ltd |
2.88 |
| Torrent Pharmaceuticals Limited |
2.61 |
| Aurobindo Pharma Limited |
2.50 |
| Mankind Pharma Limited |
2.16 |
| Alkem Laboratories Limited |
2.10 |
| Laurus Labs Limited |
1.85 |
| Zydus Lifesciences Limited |
1.83 |
| Glenmark Pharmaceuticals Limited |
1.71 |
| IPCA Laboratories Limited |
1.56 |
| Krishna Inst of Medical Sciences Ltd. |
1.31 |
| Abbott India Limited |
1.22 |
| Biocon Limited |
1.17 |
| Glaxosmithkline Pharma Ltd |
1.05 |
| Cohance Lifesciences Limited |
1.04 |
| Piramal Pharma Limited |
0.98 |
| Gland Pharma Limited |
0.98 |
| Aster DM Healthcare Limited |
0.98 |
| Syngene International Limited |
0.96 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
